3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Radiation Injuries
2
Medulloblastoma
2
Fatigue
2
Choroid Plexus Neoplasms
2
Breast Neoplasms
2
Astrocytoma
2
Spinal Cord Neoplasms
1
Sleep Wake Disorders
1
Pinealoma
1
Pain
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neuroectodermal Tumors, Primitive
1
Neoplasms
1
Neoplasm Metastasis
1
Meningioma
1
Memory Disorders
1
Gliosarcoma
1
Glioma, Subependymal
1
Glioma
1
Glioblastoma
1
Familial ependymoma
1
Ependymoma
1
Depression
1
Craniopharyngioma
1
Cognitive Dysfunction
1
Cognition Disorders
1
Central Nervous System Neoplasms
1
Cancer Pain
1
Interventions
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
morphine, naltrexone combination
1
Therapeutics
1
Tapentadol
1
Nerve Block
1
Naltrexone
1
Morphine
1
Fentanyl
1
Anesthetics, Local
1
Anesthesia, Local
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Chronic Pain
×
Donepezil
×
Clear all
No trials found.